Disease relevance of Body Height

• L3 BMD correlated with both the body height (r = 0.335, p less than 0.0001) and the body weight (r = 0.340, p less than 0.0001) [1].
• RESULTS: Within this group of engine drivers, age, family history of myocardial infarction, systolic blood pressure and low body height were independent predictors of myocardial infarction, but diabetes, elevated serum cholesterol and smoking were not [2].
• KET/BM had a significant effect on walking speed after controlling for number of chronic conditions, balance, use of walking aid, joint pain, age, and body height and mass [3].
• WPA, BMD, body height, height gain, weight, weight gain, dietary polyunsaturated fat and sodium were correlated with delta BMD [4].
• The results obtained were as follows: (1) Among the six subjects, inhibition of maxillary forward growth was found in four subjects at ages before the maximum pubertal growth in body height occurred, resulting from occlusal interference of anterior cross bite [5].

Psychiatry related information on Body Height

• After adjustment by analysis of covariance for differences between the subject groups in body height, age and sex distribution, significantly (P less than 0.001) lower concentrations of 5-HIAA and HVA were found in the melancholia patients than in the controls [6].

High impact information on Body Height

• After adjustment for differences in body height and age between controls and patients, the difference in 5-HIAA level became even more marked [7].
• Blood hemoglobin concentration was positively correlated with relative body height and with serum IGF-I and IGFBP-3 levels (P = .001 to .02), but not with the concentrations of EPO [8].
• Mean body height decreased by 0.57 inches in the observation group and .06 inches in the gallium nitrate group [9].
• Analysis of covariance was performed to calculate mean values of BUA, OC, and DPD/Cr(urine) based on the specified categories of Hcy and vitamin B12 and adjusted for several confounders (potential confounders were age, sex, body weight, body height, current smoking [yes/no], mobility, cognition) [10].
• METHOD: Participants were 1,103 girls initially assessed in grades 6-9 in school districts in Arizona and California. Each year, students completed the McKnight Risk Factor Survey, had body height and weight measured, and underwent a structured clinical interview [11].

Chemical compound and disease context of Body Height

• Those who died had significantly lower levels of total protein, serum albumin, total cholesterol, triglyceride, BUN, serum creatinine, body weight, body height, diastolic blood pressure, and duration of hemodialysis than those who survived [12].
• The effect of the following covariates was evaluated by analysis of covariance: age, sex, oral contraceptives, body height, body weight, body mass index, number of cigarettes smoked, tar exposure from smoking, several indices of dietary caffeine consumption, intake of sauerkraut, and country of residence (Germany, Bulgaria or Slovakia) [13].
• Neither total testosterone nor apparent free testosterone concentration was associated with any bone variables after adjusting for age, body weight, body height, and lean body mass and 17beta-estradiol level [14].
• Body weight, body height, and 24-hour urinary creatinine excretion (absolute and per kilogram body weight) were lower in older age groups [15].
• Age, body weight, body height, Tanner status, testicular size, serum luteinizing hormone (LH), prolactin (PRL), thyroxine (T4), triiodothyronine (T3), and thyroid-stimulating hormone (TSH) levels were not statistically different between Yucheng and control boys in the subgroups of before and at the age of puberty [16].

Biological context of Body Height

• RESULTS: At the randomization, the subjects with the VDR TaqI Tt or tt genotype had a greater body height than the subjects with TT genotype (P=0.001) [17].
• Bioelectrical impedance analysis (BIA) for body composition has been based on the volume conductor model that results in the mathematical relationship Ht2/R approximately FFM, where Ht is body height, R is whole body resistance or impedance, and FFM is fat-free mass [18].
• Limitations concerning the use in children of the relationship between plasma creatinine and body height to derive glomerular filtration rate [19].
• Model-based time-dependent cumulative dose estimates (area under the curve (AUC) of the lipid-adjusted serum TCDD concentration over time) were obtained for members of the full cohort with recorded body height and weight (n = 4049), as this information is required by the MPTK model to compute dose [20].
• The trials were performed in 15 male healthy volunteers (age 21-25 years, body weight 62-94 kg, body height 172-187 cm) with known N-acetylation and debrisoquine type hydroxylation phenotype [21].

Anatomical context of Body Height

• Disease duration was correlated with vertebral body height (P = 0.001) or intervertebral space height (P = 0.02), and lumbar mobility with thorax expansion (P = 0.004); DISH severity was correlated with basal (P = 0.04) and peak (P = 0.01) glucose levels after glucose load [22].
• No definite correlation was demonstrated with left ventricular, adrenal, or lymph node fatty infiltration, or with hepatic fatty change, body height, age of patient, or blood glucose [23].
• Spinal cord and vertebral canal sagittal diameter, vertebral body height at C2 to 5, body length at C3 to 5, and dorsal spine length of C2 were measured on lateral views [24].
• The most evident effect of FMRP deficit in sexes combined was in decreasing body height and limb length, and in increasing head height and the degree of connective tissue involvement (measured by the middle finger extension angle) [25].

Associations of Body Height with chemical compounds

• It was found that these groups did not differ in concentrations of 5-HIAA or HVA, at least not when values were corrected for age, sex, and body height [26].
• No significant relationships were found between substance P levels and age, sex or body height [27].
• Among the other factors studied, body height contributed most to the variance in both 5-HIAA and HVA concentrations; the levels of MHPG increased with age [28].
• Carboplatin clearance was significantly related to creatinine clearance and body height, explaining 73% of the interindividual variability [29].
• A significant negative correlation (-0.45) between body height and maximum nocturnal serum melatonin level was found [30].

Gene context of Body Height

• Growth hormone (GH) has long been known to be a primary determinant of body height and an important regulator of body metabolism, yet the cellular and molecular bases for these effects of GH are only beginning to be understood [31].
• After six-month treatment with recombinant human growth hormone (rhGH), serum level of IGFBP-3 in 59 GHD significantly increased from 1.3 +/- 0.7 mg/L to 2.7 +/- 0.9 mg/L, accompanied by an increase of body heights, growth velocities and serum level of IGF-1 [32].
• A standard dose of 2% mepivacaine with adrenaline, 5 micrograms.ml-1, (0.1 ml per cm body height) was given and the patients' ability to discriminate stimuli within dermatomes T8, T10, T12, L2, L4 and S1 was investigated at five min intervals for 30 min after injection [33].
• IGF-1 levels were correlated with body height (P=0.001, r=0.223), body weight (P=0.002,r=-0.188) and BMI (P=0.039, r=0.128) [34].
• These results suggest that DNA sequence variation in the MC4R locus may contribute to the gain in body height from childhood to adulthood [35].

Analytical, diagnostic and therapeutic context of Body Height

• Bilirubin and gamma-glutamyl transpeptidase levels in serum were measured, a physical examination was performed, which included body height and weight, and calculation of BMI [36].

References